Thomas Hope, MD, discusses the efficacy of the 68Ga-PSMA-11 PET for the detection of pelvic nodal metastases in patients intermediate- to high-risk prostate cancer considered for radical prostatectomy with lymph node dissection.
Thomas Hope, MD
Advertisement
Articles by Thomas Hope, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
4
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
5